Darbilen (Darbepoetin alfa PFS) 100 μg/ml

Darbepoetin alfa 100 μg/ml PFS is an erythropoiesis-stimulating agent used to support red blood cell production. This formulation is designed for subcutaneous or intravenous administration in anemia management. Store between 2-8°C to maintain potency. Seek medical guidance before use.

Strength

100 μg/ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Glenmark Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Darbepoetin alfa is used to treat anemia caused by chronic kidney disease or chemotherapy in cancer patients. It helps increase hemoglobin levels and reduce the need for blood transfusions. This medication stimulates the bone marrow to produce more red blood cells. Patients with low red blood cell counts may benefit from this treatment.

Side Effects

This medication works gradually to improve energy levels and reduce fatigue associated with low red blood cell counts. Users may notice improved ability to perform daily activities over time. Some patients report reduced shortness of breath and dizziness as hemoglobin levels rise. Effects vary based on individual health conditions and treatment duration.

Precautions & Warnings

Keep this medication refrigerated between 2-8°C and protect from light. Do not freeze or shake the pre-filled syringe. Inspect the solution for particles or discoloration before use. Discard any unused portion after opening. Always follow healthcare provider instructions for proper handling and disposal.

Avoid Interactions

Certain medications may affect how darbepoetin alfa works, including immunosuppressants and other drugs that influence blood cell production. Avoid alcohol as it may worsen anemia symptoms. Inform your doctor about all medications and supplements you are taking. Regular monitoring of blood parameters is recommended during treatment.

Frequently Asked Questions

It is used to treat anemia in patients with chronic kidney disease or undergoing chemotherapy.

It is given as an injection under the skin or into a vein, as directed by a healthcare professional.

This medication requires a prescription and should only be obtained through licensed pharmacies or healthcare providers.

Possible side effects include high blood pressure, headache, and injection site reactions.

Store in the refrigerator between 2-8°C and protect from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.